Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker, José Carlos Bouso Saiz, Serdar M. Dursun, Jaime E. C. Hallak & Rafael G. Dos Santos. (2022) Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability. Expert Opinion on Drug Safety 21:6, pages 789-801.
Read now
Read now
Helle Kaasik & Kairi Kreegipuu. (2020) Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life. Journal of Psychoactive Drugs 52:3, pages 255-263.
Read now
Read now
Maha N. Mian, B. R. Altman & M. Earleywine. (2020) Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness. Journal of Psychoactive Drugs 52:2, pages 130-137.
Read now
Read now
Alexandra VSL Rodrigues, Francisco Jcg Almeida & Maria A Vieira-Coelho. (2019) Dimethyltryptamine: Endogenous Role and Therapeutic Potential. Journal of Psychoactive Drugs 51:4, pages 299-310.
Read now
Read now
Andrew Kristoffer Dean. (2019) The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist. Journal of Marketing Management 35:9-10, pages 818-844.
Read now
Read now
Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug & Kim P. C. Kuypers. (2019) Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. Journal of Psychoactive Drugs 51:2, pages 123-134.
Read now
Read now
Caroline Dorsen, Joseph Palamar & Michele G. Shedlin. (2019) Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study. Addiction Research & Theory 27:2, pages 68-75.
Read now
Read now
Joselaine Ida Cruz & Solange Aparecida Nappo. (2018) Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?. Journal of Psychoactive Drugs 50:3, pages 247-255.
Read now
Read now
Veronika Kavenská & Hana Simonová. (2015) Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks. Journal of Psychoactive Drugs 47:5, pages 351-359.
Read now
Read now
Clancy Cavnar. (2014) The Effects of Ayahuasca Ritual Participation on Gay and Lesbian Identity. Journal of Psychoactive Drugs 46:3, pages 252-260.
Read now
Read now
Rafael Guimarães dos Santos. (2013) Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology. Journal of Psychoactive Drugs 45:1, pages 68-78.
Read now
Read now
Rachel Harris & Lee Gurel. (2012) A Study of Ayahuasca Use in North America. Journal of Psychoactive Drugs 44:3, pages 209-215.
Read now
Read now
David Luke. (2010) Rock Art or Rorschach: Is there More to Entoptics than Meets the Eye?. Time and Mind 3:1, pages 9-28.
Read now
Read now
Paulo
Cesar Ribeiro Barbosa, Irene
Maurício Cazorla, Joel
Sales Giglio & Rick Strassman. (2009) A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects. Journal of Psychoactive Drugs 41:3, pages 205-212.
Read now
Read now
Articles from other publishers (71)
Valerie Michelle Vallejo Vilaró & César Alveiro Montoya Agudelo. (2024) Reivindicación del derecho a la salud frente al desconocimiento del yagé como posibilidad terapéutica. Revista Latinoamericana de Derecho Social, pages 151-184.
Crossref
Crossref
Tiago Arruda Sanchez, Lucas Rego Ramos, Felipe Araujo, Eduardo Ekman Schenberg, Mauricio Yonamine, Isabela Lobo, Draulio Barros de Araujo & Luis Eduardo Luna. (2024) Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study. Journal of Ethnopharmacology 320, pages 117430.
Crossref
Crossref
Ellen James, David Erritzoe, Tiffanie Benway, Zelah Joel, Christopher Timmermann, Meghan Good, Claudio Agnorelli, Brandon M. Weiss, Tommaso Barba, Graham Campbell, Michelle Baker Jones, Charlotte Hughes, Helen Topping, Malcolm Boyce & Carol Routledge. (2024) Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial. Frontiers in Psychiatry 14.
Crossref
Crossref
Johannes G. Ramaekers, Pablo Mallaroni, Lilian Kloft, Johannes T. Reckweg, Stefan W. Toennes, Kim van Oorsouw & Natasha L. Mason. (2023)
Altered State of Consciousness and Mental Imagery as a Function of
N
,
N
-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users
. Journal of Cognitive Neuroscience 35:9, pages 1382-1393.
Crossref
Crossref
Joana Gonçalves, Ângelo Luís, Eugenia Gallardo & Ana Paula Duarte. (2023) A Systematic Review on the Therapeutic Effects of Ayahuasca. Plants 12:13, pages 2573.
Crossref
Crossref
Ricarda Evens, Marianna Elisa Schmidt, Tomislav Majić & Timo Torsten Schmidt. (2023) The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics. Therapeutic Advances in Psychopharmacology 13.
Crossref
Crossref
Daniel Perkins, Broc A. Pagni, Jerome Sarris, Paulo C. R. Barbosa & Richard Chenhall. (2022) Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study. Frontiers in Pharmacology 13.
Crossref
Crossref
Joana Gonçalves, Ângelo Luís, Eugenia Gallardo & Ana Paula Duarte. (2022) Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca. Molecules 27:18, pages 5760.
Crossref
Crossref
Edward James, Joachim Keppler, Thomas L Robertshaw & Ben Sessa. (2022) N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37:3.
Crossref
Crossref
Emilija Glavonic, Milos Mitic & Miroslav Adzic. (2022) Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction. Journal of Neuroscience Research 100:4, pages 947-969.
Crossref
Crossref
David Luke. (2020) Anomalous Psychedelic Experiences: At the Neurochemical Juncture of the Humanistic and Parapsychological. Journal of Humanistic Psychology 62:2, pages 257-297.
Crossref
Crossref
Tasha L. Golden, Susan Magsamen, Clara C. Sandu, Shuyang Lin, Grace Marie Roebuck, Kathy M. Shi & Frederick S. Barrett. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
35
70
.
Maggie K. Kiraga, Natasha L. Mason, Malin V. Uthaug, Kim I.M. van Oorsouw, Stefan W. Toennes, Johannes G. Ramaekers & Kim P. C. Kuypers. (2021) Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being. Frontiers in Pharmacology 12.
Crossref
Crossref
M. V. Uthaug, N. L. Mason, S. W. Toennes, J. T. Reckweg, E. B. de Sousa Fernandes Perna, K. P. C. Kuypers, K. van Oorsouw, J. Riba & J. G. Ramaekers. (2021) A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Psychopharmacology 238:7, pages 1899-1910.
Crossref
Crossref
Simon G. D. Ruffell, Nige Netzband, WaiFung Tsang, Merlin Davies, Antonio Inserra, Matthew Butler, James J. H. Rucker, Luís Fernando Tófoli, Emma Louise Dempster, Allan H. Young & Celia J. A. Morgan. (2021) Ceremonial Ayahuasca in Amazonian Retreats—Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study. Frontiers in Psychiatry 12.
Crossref
Crossref
Franklin KingIVIVRebecca Hammond. (2021) Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field. FOCUS 19:2, pages 190-196.
Crossref
Crossref
María Gómez-Sousa, Daniel F. Jiménez-Garrido, Genís Ona, Rafael Guimaraes dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar-CórcolesJosé Carlos Bouso. (2021) Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users. Journal of Clinical Psychopharmacology 41:2, pages 163-171.
Crossref
Crossref
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David J. Nutt & David Erritzoe. (2020) Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies. Acta Psychiatrica Scandinavica 143:2, pages 101-118.
Crossref
Crossref
Marina Goulart da Silva, Guilherme Cabreira Daros & Rafael Mariano de Bitencourt. (2021) Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases. Behavioural Brain Research 400, pages 113003.
Crossref
Crossref
Victor Distefano Wiltenburg, Dianne da Rocha Prado & Fúlvio Rieli Mendes. 2021. Drugs and Human Behavior. Drugs and Human Behavior
479
510
.
Natasha L. Mason & Kim P. C. Kuypers. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
117
136
.
Mauricio Diament, Bruno Ramos Gomes & Luis Fernando Tófoli. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
63
79
.
Marta Valle, Elisabet Domínguez-Clavé, Matilde Elices, Juan Carlos Pascual, Joaquim Soler, José A. Morales-García, Ana Pérez-Castillo & Jordi Riba. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
1
19
.
Fernanda Palhano-Fontes, Bruno Lobão Soares, Nicole Leite Galvão-Coelho, Emerson Arcoverde & Draulio B. Araujo. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
113
124
.
Arthur Maneuvrier & Hannes Westermann. (2020) The Phi Angle: A Theoretical Essay on Sense of Presence, Human Factors, and Performance in Virtual Reality. PRESENCE: Virtual and Augmented Reality 29, pages 141-169.
Crossref
Crossref
Nige Netzband, Simon Ruffell, S. Linton, W. F. Tsang & T. Wolff. (2020) Modulatory effects of ayahuasca on personality structure in a traditional framework. Psychopharmacology 237:10, pages 3161-3171.
Crossref
Crossref
Laura Orsolini, Stefania Chiappini, Duccio Papanti, Roberto Latini, Umberto Volpe, Michele Fornaro, Carmine Tomasetti, Federica Vellante & Domenico De Berardis. (2020) How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy. Human Psychopharmacology: Clinical and Experimental 35:3.
Crossref
Crossref
Marika Renelli, Jenna Fletcher, Kenneth W. Tupper, Natasha Files, Anya Loizaga-Velder & Adele Lafrance. (2018) An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 25:2, pages 437-444.
Crossref
Crossref
Jakub Benko & Stanislava Vranková. (2020) Natural Psychoplastogens As Antidepressant Agents. Molecules 25:5, pages 1172.
Crossref
Crossref
Daniel F. Jiménez-Garrido, María Gómez-Sousa, Genís Ona, Rafael G. Dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar-Córcoles & José Carlos Bouso. (2020) Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination. Scientific Reports 10:1.
Crossref
Crossref
Eric Bui, Franklin King & Andrew Melaragno. (2019) Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches. General Psychiatry 32:6, pages e100136.
Crossref
Crossref
Simão, Gonçalves, Duarte, Barroso, Cristóvão & Gallardo. (2019) Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review. Medicines 6:4, pages 106.
Crossref
Crossref
Avery Sapoznikow, Zachary Walsh, Kenneth W. Tupper, Earth Erowid & Fire Erowid. (2019) The influence of context on ayahuasca experiences: An analysis of experience reports. Journal of Psychedelic Studies 3:3, pages 288-294.
Crossref
Crossref
Edgar Antonio Estrella-Parra, Julio Cesar Almanza-Pérez & Francisco Javier Alarcón-Aguilar. (2019) Ayahuasca: Uses, Phytochemical and Biological Activities. Natural Products and Bioprospecting 9:4, pages 251-265.
Crossref
Crossref
Tom John Wolff, Simon Ruffell, Nigel Netzband & Torsten Passie. (2019) A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism. Journal of Psychedelic Studies 3:3, pages 295-307.
Crossref
Crossref
Elisabet Domínguez-Clavé, Joaquim Soler, Juan C. Pascual, Matilde Elices, Alba Franquesa, Marta Valle, Enric Alvarez & Jordi Riba. (2018) Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. Psychopharmacology 236:2, pages 573-580.
Crossref
Crossref
Jonathan Hamill, Jaime Hallak, Serdar M. Dursun & Glen Baker. (2019) Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Current Neuropharmacology 17:2, pages 108-128.
Crossref
Crossref
Miroslav Horák & Nahanga Verter. 2019. Ayahuasca in the Czech Republic: Extended Version. Ayahuasca in the Czech Republic: Extended Version.
Timothy I. Michaels, Jennifer Purdon, Alexis Collins & Monnica T. Williams. (2018) Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry 18:1.
Crossref
Crossref
Lindsay P. Cameron & David E. Olson. (2018)
Dark Classics in Chemical Neuroscience:
N
,
N
-Dimethyltryptamine (DMT)
. ACS Chemical Neuroscience 9:10, pages 2344-2357.
Crossref
Crossref
M. V. Uthaug, K. van Oorsouw, K. P. C. Kuypers, M. van Boxtel, N. J. Broers, N. L. Mason, S. W. Toennes, J. Riba & J. G. Ramaekers. (2018) Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology 235:10, pages 2979-2989.
Crossref
Crossref
Marika Renelli, Jenna Fletcher, Anja Loizaga-Velder, Natasha Files, Kenneth Tupper & Adele Lafrance. 2018. Embodiment and Eating Disorders. Embodiment and Eating Disorders
214
230
.
Natasha L. Mason & Kim P. C. Kuypers. (2018) Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics. Journal of Psychedelic Studies 2:1, pages 45-52.
Crossref
Crossref
Robson Savoldi, Daniel Polari, Jaquelinne Pinheiro-da-Silva, Priscila F. Silva, Bruno Lobao-Soares, Mauricio Yonamine, Fulvio A. M. Freire & Ana C. Luchiari. (2017) Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish. Frontiers in Behavioral Neuroscience 11.
Crossref
Crossref
Rafael G. dos Santos, José Carlos Bouso & Jaime E. C. Hallak. (2017) Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology 7:4, pages 141-157.
Crossref
Crossref
Joseph M. Barnby & Vaughan Bell. (2017) The Sensed Presence Questionnaire (SenPQ): initial psychometric validation of a measure of the “Sensed Presence” experience. PeerJ 5, pages e3149.
Crossref
Crossref
Benjamin J. Malcolm & Kelly C. Lee. (2017) Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?. Mental Health Clinician 7:1, pages 39-45.
Crossref
Crossref
Miroslav Horák. 2017. AYAHUASCA V ČESKÉ REPUBLICE. AYAHUASCA V ČESKÉ REPUBLICE.
S.M. Phipps & O. Grundmann. 2017.
1
44
.
Rafael G dos Santos, Fermanda M Balthazar, José C Bouso & Jaime EC Hallak. (2016) The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. Journal of Psychopharmacology 30:12, pages 1230-1247.
Crossref
Crossref
Miroslav Horák & Šárka Vosáhlová. (2016) Tradiční amazonská medicína v české subkultuře. Anthropologia integra 7:2, pages 47-55.
Crossref
Crossref
Paulo Cesar Ribeiro Barbosa, Rick J. Strassman, Dartiu Xavier da Silveira, Kelsy Areco, Robert Hoy, Jessica Pommy, Robert Thoma & Michael Bogenschutz. (2016) Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry 71, pages 95-105.
Crossref
Crossref
Elisabet Domínguez-Clavé, Joaquim Soler, Matilde Elices, Juan C. Pascual, Enrique Álvarez, Mario de la Fuente Revenga, Pablo Friedlander, Amanda Feilding & Jordi Riba. (2016) Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin 126, pages 89-101.
Crossref
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Crossref
Ede Frecska, Petra Bokor & Michael Winkelman. (2016) The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology 7.
Crossref
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa & Jaime E. C. Hallak. (2016) Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies. Revista Brasileira de Psiquiatria 38:1, pages 65-72.
Crossref
Crossref
Miroslav Horák, Romana Lukášová & Šárka Vosáhlová. (2015) Glokalizace ayahuasky v ČR a možnosti jejího terapeutického využití v místních podmínkách. Anthropologia integra 6:2, pages 7.
Crossref
Crossref
Rif S. El‐Mallakh, John H. Halpern & Henry David Abraham. 2015. Psychiatry. Psychiatry
1480
1506
.
Veronika Kavenská & Hana Simonová. (2014) Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu. Anthropologia integra 5:1, pages 51.
Crossref
Crossref
José Carlos Bouso & Jordi Riba. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca
95
109
.
Xavier Fernández, Rafael Guimarães dos Santos, Marta Cutchet, Sabela Fondevila, Débora González, Miguel Ángel Alcázar, Jordi Riba, José Carlos Bouso & Josep María Fábregas. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca
183
196
.
Michelle Corbin. (2012) Tactics of Legitimation in the Psychedelic Sciences. American Behavioral Scientist 56:10, pages 1413-1433.
Crossref
Crossref
Shawn A. Tassone. (2012) Altars and Icons: The Surgical Suite as a Sacred Ritual. EXPLORE 8:5, pages 299-303.
Crossref
Crossref
Paulo Cesar Ribeiro Barbosa, Suely Mizumoto, Michael P. Bogenschutz & Rick J. Strassman. (2012) Health status of ayahuasca users. Drug Testing and Analysis 4:7-8, pages 601-609.
Crossref
Crossref
Brian T. Anderson. (2012) Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry. Anthropology of Consciousness 23:1, pages 44-59.
Crossref
Crossref
Gil Raz. (2012) Imbibing the Universe: Methods of Ingesting the Five Sprouts1. Asian Medicine 7:1, pages 65-100.
Crossref
Crossref
P.A. De Souza. (2011) Alcaloides e o chá de ayahuasca: uma correlação dos "estados alterados da consciência" induzido por alucinógenos. Revista Brasileira de Plantas Medicinais 13:3, pages 349-358.
Crossref
Crossref
MW Johnson, WA Richards & RR Griffiths. (2008) Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 22:6, pages 603-620.
Crossref
Crossref
Kenneth W. Tupper. (2008) The globalization of ayahuasca: Harm reduction or benefit maximization?. International Journal of Drug Policy 19:4, pages 297-303.
Crossref
Crossref
Robert S. Gable. (2006) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:1, pages 24-34.
Crossref
Crossref
Timothy I. Michaels, Jennifer Purdon, Alexis Collins & Monnica Williams. (2018) Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of the Literature. SSRN Electronic Journal.
Crossref
Crossref